Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$614,368
-$59,729 QoQ
Shares Held
3,240
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#798
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. AZN ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $614,368 | 3,240 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $674,097 | 3,418 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||